MMJ International Holdings, a pharmaceutical cannabinoid developer pursuing FDA-regulated treatments for Huntington’s disease and multiple sclerosis, is questioning the factual foundation of the Attorney General’s April 28, 2026 marijuana rescheduling order. The order was published at 91 Federal Register 22714.
MMJ is a petitioner in the pending consolidated marijuana rescheduling litigation before the United States Court of Appeals for the District of Columbia Circuit. The company’s challenge follows new testimony from Oklahoma law enforcement officials describing extensive failures within that state’s medical marijuana regulatory system.
The revelations were reported by NC Newsline on November 13, 2026. They present a significant challenge to the federal government’s characterization of state medical marijuana regulatory systems as sufficiently developed to prevent diversion and protect public safety.
In the final order, the Attorney General asserted that state medical marijuana regulatory programs had matured into comprehensive systems. “These state regimes have developed robust infrastructure for preventing diversion, ensuring product safety, maintaining records, and conducting facility inspections,” the Attorney General stated in the April 28, 2026 order.
Those findings helped justify a new federal registration process under 21 CFR § 1301.13(k), allowing qualifying state-licensed medical marijuana operators to obtain federal registrations that rely substantially on existing state oversight.
Lieutenant Colonel Mitch Smith of the Oklahoma Bureau of Narcotics and Dangerous Drugs described substantial problems arising from Oklahoma’s medical marijuana licensing program during testimony before North Carolina policymakers, according to the November 13, 2026 NC Newsline report.
Approximately 8,400 commercial marijuana growers operated in Oklahoma by 2021. The state initially imposed no cap on the number of commercial grow licenses or the amount of marijuana that could be cultivated.
Excess production contributed to diversion into illicit markets. Investigators identified 27 groups from at least 16 countries allegedly operating illegally within Oklahoma.
Enforcement officials reported recently seizing more than 50,000 illegal marijuana plants. Oklahoma allocates approximately $10 million annually to a marijuana enforcement unit consisting of 48 agents and analysts.
Lt. Colonel Smith also described problems involving straw ownership arrangements, abandoned cultivation facilities, pesticide contamination concerns, and the substantial resources required to investigate illegal operations. These statements do not establish that all Oklahoma medical marijuana licensees are noncompliant.
“The Attorney General told the American public that state marijuana programs had developed robust systems to prevent diversion and protect public health. Oklahoma’s own narcotics enforcement officials are describing serious failures in precisely those areas,” said Duane Boise, President and Chief Executive Officer of MMJ International Holdings.
“MMJ is not opposed to marijuana derived medicine. We are opposed to replacing scientific evidence and enforceable federal safeguards with regulatory assumptions that have not been adequately demonstrated,” Boise added.
MMJ is asking what evidence supports the Attorney General’s conclusions and how the federal government accounted for documented failures in state marijuana enforcement.
“If the federal government reviewed these state programs, where is the supporting evidence? What inspections, diversion assessments, enforcement findings, and product-safety evaluations formed the basis for the Attorney General’s conclusions?” Boise said.
Summit Returns to Washington The IgniteIt Capital & Policy Summit returns to the Grand Hyatt Washington on Wednesday, November 18,…
Court Orders Regulated Cultivation Nepal's Supreme Court has ordered the government to make the "necessary arrangements" for the "controlled cultivation…
Operator Warns Legalization Alone Is Not Enough In an op-ed published by Marijuana Moment, Perlow argued that lawmakers must act…
Market Projection Details Australia's medical cannabis market is predicted to exceed USD 2.67 billion by 2035, according to a recent…
Oklahoma Official Testifies Before North Carolina Panel Lt. Col. Mitch Smith with the Oklahoma Bureau of Narcotics and Dangerous Drugs…
Democratic Leader Signals Medical Cannabis Vote North Carolina House Minority Leader Robert Reives (D) indicated on Tuesday that the new…